Pneumonic plague in an untreated plague-vaccinated individual.
about
Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccineProtecting against plague: towards a next-generation vaccineInfectious diseases. Annual review of significant publications (1968)Plague Vaccine Development: Current Research and Future TrendsYersinia pestis--etiologic agent of plagueImmune defense against pneumonic plagueMucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.Levofloxacin cures experimental pneumonic plague in African green monkeys.Milestones in progression of primary pneumonic plague in cynomolgus macaques.Yersinia pestis (plague) vaccines.Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.Epidemiologic determinants for modeling pneumonic plague outbreaksImpact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.Current challenges in the development of vaccines for pneumonic plague.Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccineDeveloping live vaccines against plague.Prophylaxis and therapy of plague.The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague.Plague: Infections of Companion Animals and Opportunities for Intervention.Cell-mediated protection against pulmonary Yersinia pestis infection.Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
P2860
Q24672915-44F4DB99-4265-476A-A617-BD957B349228Q26823422-A47D395C-6D63-4437-BCC4-3C36302B2A6CQ27486424-EC189744-B517-4373-8D64-AA8CB57C4615Q28066875-D3F2DF18-30F5-46E7-89F0-229B5CCB03BCQ29619320-0DCC107D-1801-44EF-83CA-FC2C4CF02431Q33584403-D008B5FE-EDD5-4DF6-BB85-CA2CBCB6EFA6Q33824782-0A615DB0-1C38-4D53-BDAB-AA284A38E033Q33828874-689780FE-075E-4820-BF67-E2C0AB7177D9Q33963187-2E2F2031-85E2-47AB-9A32-D3E503A5F2BBQ34324211-F724D1F2-4FC6-46CF-BFD1-3C9B7F868A73Q34348619-2CDCC6C9-41DA-4305-ACA8-3CD6DD5FE43BQ34529303-B67D733C-973F-4D33-AE87-17320E02F682Q35005186-09809D53-1867-451C-AF23-6F57F57554ADQ35880203-4EF8F8AF-CF55-4AF0-81E8-B75E4E93251DQ35912654-824DE8DA-7B46-4314-90E6-16E1093C6B4AQ36628038-65097816-6A10-4D19-8D1B-EA3FE87E1812Q37190877-DB839BC9-8B96-4E00-BDBD-E836A8F90815Q37599376-F54BFF8F-F26E-4758-A0E3-355AA3DBB215Q38131537-6AAE05C0-C1BE-47DD-B259-065DE09D3B24Q38589273-E4E84811-EB12-419B-8081-F453E317ADF9Q38612499-734F16DE-6915-4636-8358-D07092963A59Q39393406-E0C2D92F-C825-4520-8BE4-2CF664B00D07Q41434206-E3FE4567-5399-4EC4-BE43-9B438AC82522Q41451306-A7728525-53C1-4C35-BD7C-6676F4457BD6
P2860
Pneumonic plague in an untreated plague-vaccinated individual.
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
1967年论文
@zh
1967年论文
@zh-cn
name
Pneumonic plague in an untreated plague-vaccinated individual.
@en
type
label
Pneumonic plague in an untreated plague-vaccinated individual.
@en
prefLabel
Pneumonic plague in an untreated plague-vaccinated individual.
@en
P1476
Pneumonic plague in an untreated plague-vaccinated individual.
@en
P2093
J L Stockard
P304
P356
10.1001/JAMA.1967.03130170165036
P407
P577
1967-10-01T00:00:00Z